BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust is a closed-end, multi-asset term trust managed by BlackRock. The fund seeks to provide total return and income through a combination of current income, current gains, and long-term capital appreciation by investing across equity and debt securities, with the flexibility to use option-writing strategies and to access both public and private market opportunities. Its portfolio is designed to be broadly diversified, spanning asset classes and market segments rather than concentrating on a single sector or style. The trust is used by investors seeking a professionally managed vehicle that blends income generation with capital appreciation potential inside a single portfolio structure. As a term trust, it has a defined lifespan that distinguishes it from perpetual closed-end funds and shapes how it is used in the market. BlackRock Capital Allocation Term Trust plays a role in the allocation and income-oriented segment of the investment company market.
$13.02
-$0.12 (-0.91%)
EOD Oct 16, 2026
Revenue grew 13.1%, still solid.
Even for strong businesses, today's 6x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
6.2x earnings, 4.2x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$224M
▲ +13.1% YoY
Net Income (TTM)
$222M
▲ +14.2% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
$330M
▼ -7.1% YoY
Op. Cash Flow (TTM)
$330M
▼ -7.1% YoY
Net Debt
-$7M
Net Cash Position
Cash & Equiv.
$7M
3Y CAGR: -27.6%
Continue Research
Is BlackRock Capital Allocation Term Trust (BCAT) overvalued?
At a P/E of 6.2 and a price-to-free-cash-flow of 4.2, BlackRock Capital Allocation Term Trust (BCAT) trades below a two-stage DCF intrinsic value of about $53.81 per share, so at $13.02 the stock looks undervalued (313.3% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, BlackRock Capital Allocation Term Trust scores 45/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 25.5%; see dividend safety for coverage and history. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
What is BlackRock Capital Allocation Term Trust's fair value?+
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $53.81 per share for BCAT, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $40.36. At today's $13.02, that puts the stock about 313.3% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Is BlackRock Capital Allocation Term Trust a high-quality business?+
BlackRock Capital Allocation Term Trust scores 45 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which makes it a mixed business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Does BlackRock Capital Allocation Term Trust (BCAT) pay a dividend, and how much?+
Yes, BlackRock Capital Allocation Term Trust pays a regular dividend of about $3.32 per share per year (typically in quarterly installments), a yield of roughly 25.5% at the current price. That is a payout ratio of about 158.9% of earnings, so the dividend is stretched at this level. BlackRock Capital Allocation Term Trust has grown the dividend at roughly 26.5% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For BCAT's full payout history, growth streak and dividend-safety score, see the dividends tab.
Is BlackRock Capital Allocation Term Trust a good stock to buy right now?+
That depends on valuation and quality together, not either alone. BCAT currently trades below its estimated intrinsic value and scores 45/100 on quality (mixed). It also yields about 25.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Asset Management
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.